IL6 and neoplasm: However, given our findings, herewith we delve deeper into the role of TNFi within the ICI-treated tumor environment as well as the potential mechanistic advantage of looking into other SSIAs for irAE therapy such as IL-6 antagonists which have been suggested to enhance the anti-tumor efficacy of ICIs (23).